References
- Coats’GForms of retinal diseases with massive exudationRoyal London Ophthalmic Hosp Rep190817440525
- SmithenLMBrownGCBruckerAJYannuzziLAKlaisCMSpaideRFCoats’ disease diagnosed in adulthoodOphthalmology200511261072107815882905
- CahillMO’KeefeMAchesonRMulvihillAWallaceDMooneyDClassification of the spectrum of Coats’ disease as subtypes of idiopathic retinal telangiectasis with exudationActa Ophthalmol Scand200179659660211782226
- ShieldsJAShieldsCLHonavarSGDemirciHCaterJClassification and management of Coats disease: the 2000 Proctor LectureAm J Ophthalmol2001131557258311336931
- GhassemiFShieldsCLMashayekhiAFluorescein angiographic findings in Coats’ diseaseOral presentation in World Ophthalmology Congress 2012February 16–20, 2012Abu Dhabi, United Arab Emirates
- GhassemiFSabourSCoats disease and cytomegalovirus infectionIran J Ophthalmol20122427578 Available from: http://irjo.org/browse.php?a_id=669&slc_lang=en&sid=1&ftxt=1Accessed December 20, 2016
- JonesJHKrollAJLouPLRyanEACoats’ diseaseInt Ophthalmol Clin200141418919811698747
- EgbertPRChanCCWinterFCFlat preparations of the retinal vessels in Coats’ diseaseJ Pediatr Ophthalmol1976136336339798026
- ChangMMMcLeanIWMerrittJCCoats’ disease: a study of 62 histologically confirmed casesJ Pediatr Ophthalmol Strabismus19842151631686502405
- McPherson PincusRAHenryMRBernardJHenry’s Clinical Diagnosis and Management by Laboratory Methods22nd edPhiladelphia, PAElsevier Saunders2011231244
- BusherJTSerum albumin and globulinWalkerHKHallWDHurstJWClinical Methods: The History, Physical, and Laboratory Examinations3rd edBoston, MAButterworths1990497499
- O’ConnellTXHoritaTJKasraviBUnderstanding and interpreting serum protein electrophoresisAm Fam Physician200571110511215663032
- GraySJBarronESThe electrophoretic analyses of the serum proteins in diseases of the liverJ Clin Invest194322219120016694993
- RavelRClinical Laboratory Medicine: Clinical Application of Laboratory Data6th edSt. LouisMosby1995343350
- KilicarslanAUysalARoachECAcute phase reactantsActa Medica201321227 Available from: http://www.tip.hacettepe.edu.tr/actamedica/2013/Acta13(2).pdfAccessed December 20, 2016
- AjjanRGrantPJFutersTSComplement C3 and C-reactive protein levels in patients with stable coronary artery diseaseThromb Haemost20059451048105316363249
- CojocaruIMCojocaruMMuşuroiCMuşuroiCDruţăABăcanuMStudy of some markers of inflammation in atherothrombotic pathogenesis of acute ischemic strokeRom J Intern Med2002401–410311615526546
- RidkerPMSilvertownJDInflammation, C-reactive protein, and atherothrombosisJ Periodontol2008798 Suppl1544155118673009
- D’AmbrosioALPinskyDJConnollyESThe role of the complement cascade in ischemia/reperfusion injury: implications for neuroprotectionMol Med20017636738211474130
- MunshiNCLongoDLAndersonKCPlasma Cell Disorders: Harrison’s Principles of Internal Medicine118th edNew York, NYThe McGraw-Hill Companies2012936944 Available from: http://accessmedicine.mhmedical.com/content.aspx?bookid=331§ionid=40726850Accessed December 20, 2016
- HowesJMRichardsonVRSmithKAComplement C3 is a novel plasma clot component with anti-fibrinolytic propertiesDiab Vasc Dis Res20129321622522253322
- SchroederVCarterAMDunneJMansfieldMWGrantPJProinflammatory and hypofibrinolytic phenotype in healthy first-degree relatives of patients with type 2 diabetesJ Thromb Haemost2010892080208220586918
- SeyaTNagasawaSMatsukuraMHasegawaHAtkinsonJPGeneration of C3d, g and C3d by urokinase-treated plasma in association with fibrinolysisComplement198522–31651742935360